文献速递牙体牙髓病

微创生物流体中基于生物标志物诊断牙髓炎的分析方法:系统综述

Analytical methods for biomarker-based diagnosis of pulpitis in minimally invasive biological fluids: a systematic review.
PubMed 文献 · J Endod · 2026-10-06

本系统综述纳入19项研究,评估龈沟液、牙本质液和牙髓血中炎症生物标志物的分析方法,以区分健康牙髓与不同阶段牙髓炎。ELISA使用最多(9项研究),仅3项研究正式评估诊断区分能力,部分标志物AUC达0.90-0.997,但均来自单一内部验证数据集,证据确定性低,尚无方法支持常规临床使用。

要点

  • ELISA是检测微创生物流体中牙髓炎生物标志物最常用的分析方法(9项研究)。
  • 仅3项研究评估诊断区分能力,部分标志物AUC为0.90-0.997,但均来自单一数据集。
  • 证据确定性低,尚无生物标志物分析方法支持常规临床使用。

核心结论

  • 目前尚无基于生物标志物的分析方法具有足够证据支持常规临床使用。
  • 部分生物标志物看似有前景,但比较性证据仍不足。

研究设计与样本

  • 系统综述遵循PRISMA 2020指南,并在PROSPERO前瞻性注册(CRD420261289672)。
  • 检索PubMed/MEDLINE、Embase、Scopus和Cochrane Library及灰色文献,共纳入19/6,508条记录。
  • 使用QUADAS-3评估偏倚风险,GRADE评估仅限报告个体水平区分的研究。

主要发现

  • 识别出六类分析策略:ELISA最常用(9项研究),其次为Luminex多重免疫分析、荧光分析、 cytometric bead array、其他多重免疫分析和无标记LC-MS/MS蛋白质组学。
  • 仅3/19项研究正式评估诊断区分能力,部分单个标志物和多标志物模型显示高区分性能(AUC 0.90-0.997)。
  • 所有估计均来自单一内部验证数据集,未进行分析策略间的直接比较。
  • 证据确定性低。

关键数值与推荐

  • 部分单个生物标志物和多标志物模型的AUC范围为0.90-0.997,来自3项正式评估诊断区分的研究。

临床怎么用

  • 基于当前证据,尚不能将生物标志物分析方法常规用于牙髓炎诊断。
  • 临床决策应继续依赖常规临床和影像学评估。

局限性

  • 仅3项研究正式评估诊断区分能力,且均来自单一内部验证数据集。
  • 未进行分析策略间的直接比较。
  • 证据确定性低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Inflammatory biomarkers measured in minimally invasive biological fluids are promising objective tools for diagnosing pulpitis. However, the analytical methods used to detect and quantify these biomarkers, and their diagnostic performance, have not been critically evaluated. This review aimed to identify and assess the analytical methods for detecting and quantifying inflammatory biomarkers in gingival crevicular fluid, dentinal fluid and pulpal blood to distinguish healthy pulp from different stages of pulpitis. METHODS: This systematic review followed PRISMA 2020 guidelines and was prospectively registered in PROSPERO (CRD420261289672). PubMed/MEDLINE, Embase, Scopus and the Cochrane Library were searched, alongside grey literature. Risk of bias was assessed using QUADAS-3. All included studies informed the synthesis, whereas GRADE assessment was limited to diagnostic questions from studies reporting individual-level discrimination. RESULTS: Nineteen of 6,508 records were included. Six analytical strategy categories were identified. ELISA was the most frequently used (9 studies), followed by Luminex-based multiplex immunoassays, fluorometric assays, cytometric bead array, other multiplex immunoassays, and label-free LC-MS/MS proteomics. Only 3 of the 19 studies formally evaluated diagnostic discrimination; in these three studies, some individual biomarkers and multimarker models showed high discriminatory performance (AUC 0.90-0.997), but all estimates derived from single, internally validated datasets and no direct comparisons between analytical strategies were performed. Certainty of evidence was low. CONCLUSIONS: No biomarker-based analytical approach currently has sufficient evidence tosupportroutine clinical use. Although some biomarkers appear promising, comparative evidence remains insufficient.

来源:J Endod,查看原文。版权归原作者所有。

引用

  1. Sahloul S, Englebert L, Aryanpour S, et al. Analytical methods for biomarker-based diagnosis of pulpitis in minimally invasive biological fluids: a systematic review. J Endod. 2026. PMID: 42838192. doi:10.1016/j.joen.2026.09.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。